Pulmonary Embolism Support Group
By far the most common form of pulmonary embolism is a thromboembolism, which occurs when a blood clot, generally a venous thrombus, becomes dislodged from its site of formation and embolizes to the arterial blood supply of one of the lungs. Symptoms may include difficulty breathing, pain during breathing, and more rarely circulatory instability and death.
Two new analyses link dabigatran (Pradaxa) to MI
cave76
http://www.theheart.org/article/1560169.do?utm_medium=email&utm_source=20130711_heartwire&utm_campaign=newsletter
Toronto, ON - The question of whether treatment with dabigatran etexilate (Pradaxa, Boehringer Ingelheim) increases the risk of MI is once again being raised, this time in two unrelated analyses. Both showed an increased risk of MI ranging from 38% to 70% vs comparator drugs and placebo.
I have no opinion (Tim Allen).
I'm just the messenger.
It will be interesting to see who reads the entire article (and it's links) and not just the subject heading.
I'm still watching all the results of the 'new' drugs for anti-coag for I'm sure as heck sick and tired (literally) of taking Coumadin. Waiting for the 'shake down' period to be over. And yes, I fully realize that all drugs can be dangerous.
"Although observational studies cannot be used as reliable sources to make statements of fact about the "safety, efficacy, or effectiveness" of a practice,[3] they can still be of use for some other things:
"[T]hey can: 1) provide information on real world use and practice; 2) detect signals about the benefits and risks of...[the] use [of practices] in the general population; 3) help formulate hypotheses to be tested in subsequent experiments; 4) provide part of the community-level data needed to design more informative pragmatic clinical trials; and 5) inform clinical practice."[3]"
"Correlation does not imply causation"
"yada yada yada"
Toronto, ON - The question of whether treatment with dabigatran etexilate (Pradaxa, Boehringer Ingelheim) increases the risk of MI is once again being raised, this time in two unrelated analyses. Both showed an increased risk of MI ranging from 38% to 70% vs comparator drugs and placebo.
I have no opinion (Tim Allen).
I'm just the messenger.
It will be interesting to see who reads the entire article (and it's links) and not just the subject heading.
I'm still watching all the results of the 'new' drugs for anti-coag for I'm sure as heck sick and tired (literally) of taking Coumadin. Waiting for the 'shake down' period to be over. And yes, I fully realize that all drugs can be dangerous.
"Although observational studies cannot be used as reliable sources to make statements of fact about the "safety, efficacy, or effectiveness" of a practice,[3] they can still be of use for some other things:
"[T]hey can: 1) provide information on real world use and practice; 2) detect signals about the benefits and risks of...[the] use [of practices] in the general population; 3) help formulate hypotheses to be tested in subsequent experiments; 4) provide part of the community-level data needed to design more informative pragmatic clinical trials; and 5) inform clinical practice."[3]"
"Correlation does not imply causation"
"yada yada yada"
rmb
What's MI?
missd12932
myocardial infarction [heart attack]
rmb
Duh. Thanks!
Join the Conversation
Posts You May Be Interested In
-
Look at what my best friend did with my picture!
-
We all have 24 hours in a day. How we spend these hours is important. Watching a little bit of a video about how sitting affects us made me aware of how much sitting and laying down I do. Gonna have to work on that.Your turn. Tell me another truth.